SCHEMBL8273196

SCHEMBL8273196

CC#CCn1c(N(C)CC(C)N)nc2c1c(=O)n(Cc1nc(C)cc(C)n1)c(=O)n2C

nearest known ligand 0.41

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 17/20 0.41
FAP Q12884 8/20 0.41
CHRM1 P11229 2/20 0.41
DPP9 Q86TI2 2/20 0.41
POU2F2 P09086 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
POU2F1 P14859 1/20 0.41
CHRM3 P20309 1/20 0.41
HRH2 P25021 1/20 0.41
MC4R P32245 1/20 0.41
DPP8 Q6V1X1 1/20 0.41
GHSR Q92847 1/20 0.41
ALDH1A1 P00352 1/20 0.40
TRPA1 O75762 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8273200 0.90 DPP4 (0.43) DPP4FAPCHRM1DPP9POU2F2
SCHEMBL9290387 0.89 ALDH1A1 (0.42) ADORA3ALDH1A1TRPA1
SCHEMBL8273197 0.85 DPP4 (0.41) DPP4FAPCHRM1DPP9POU2F2
SCHEMBL4474769 0.85 DPP4 (0.61) DPP4FAPCHRM1DPP9POU2F2
SCHEMBL196303 0.85 DPP4 (0.61) DPP4FAPCHRM1DPP9POU2F2
SCHEMBL4471876 0.85 DPP4 (0.58) DPP4FAPCHRM1DPP9POU2F2
SCHEMBL4475662 0.85 DPP4 (0.58) DPP4FAPCHRM1DPP9POU2F2
SCHEMBL4471886 0.85 DPP4 (0.58) DPP4FAPCHRM1DPP9POU2F2
SCHEMBL29801431 0.85 DPP4 (0.61) DPP4FAPCHRM1DPP9POU2F2
SCHEMBL196304 0.85 DPP4 (0.61) DPP4FAPCHRM1DPP9POU2F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7495002-B2 3-methyl-7-butinyl-xanthines, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-02-24 US disclosed
WO-2006029769-A1 NOVEL 3-METHYL-7-BUTINYL-XANTHINES, PRODUCTION THEREOF, AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-03-23 WO disclosed